BIOMAT Database Logo BIOMAT Database Logo

Serum C3 levels in patients with liver hydatid disease. 1976

B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos

UI MeSH Term Description Entries
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004444 Echinococcosis, Hepatic Liver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles (HYDATID CYST). Alveolar Echinococcosis, Hepatic,Echinococcosis, Hepatic Alveolar,Hydatid Cyst, Hepatic,Hydatidosis, Hepatic,Cyst, Hepatic Hydatid,Cysts, Hepatic Hydatid,Hepatic Alveolar Echinococcosis,Hepatic Echinococcosis,Hepatic Hydatid Cyst,Hepatic Hydatid Cysts,Hepatic Hydatidosis,Hydatid Cysts, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum IgE levels in patients with liver disease.
December 1981, Annals of allergy,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum IgE levels in patients with liver disease.
October 1976, The Medical journal of Australia,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
C3 Gene Functional Polymorphisms and C3 Serum Levels in Patients with Rheumatoid Arthritis.
November 2021, Immunological investigations,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum ubiquitin levels in patients with alcoholic liver disease.
April 1999, Alcoholism, clinical and experimental research,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum paraoxonase levels in patients with acute liver disease.
July 2011, Indian journal of clinical biochemistry : IJCB,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum endocan levels in patients with chronic liver disease.
January 2014, International journal of clinical and experimental medicine,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum thyroid hormone levels in patients with liver disease.
October 1979, Archives of internal medicine,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum immunoglobulins, C3 and C4 levels in patients with burns.
July 1984, Indian journal of pathology & microbiology,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
[Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
January 1976, Zeitschrift fur Rheumatologie,
B Seitanidis, and G Theodoropoulos, and D Kremastinos, and A Kalos, and B Angelopoulos
Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis.
January 2004, Hepato-gastroenterology,
Copied contents to your clipboard!